B
BDRX
Biodexa Pharmaceuticals plc
3.360
-0.070-2.04%After Hours: 3.090 -0.270 -8.04%19:50 06/05 EDT
OPEN/PREV CLOSE3.250/3.100
TODAY RANGE3.000-3.250
VOL17.73K
MARKET CAP2.25M
52 WEEK RANGE2.860-66.50
AVG VOL (3M)739.44K
% TURNOVER2.38%
TURNOVER--
P/E (TTM)-0.0077
% RANGE8.06%
EPS(TTM)-391.5114
P/E(FORWARD)-0.2766
P/B0.0018
BVPS1,698.57
DIVIDEND--
P/S230.39
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.25M
SHARES OUTSTANDING746.11K
NEXT EARNINGS09/10-09/14
FREE FLOAT746.11K
LOT SIZE1
EX-DATE04/06/2026
News
Press Releases
Financial Reports
Profile
Benzinga·06/02 21:09
12 Health Care Stocks Moving In Tuesday's After-Market Session
Barchart·05/14 07:30
Biodexa issues letter to Shareholders
Benzinga·05/05 17:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·05/05 12:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·04/09 12:08
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga·04/09 09:24
Why GameSquare Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
Benzinga·04/07 09:20
Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
TipRanks·04/05 15:28
Upcoming Stock Splits This Week (April 6-10, 2026) – Stay Invested
TipRanks·04/02 23:50
Biodexa Pharmaceuticals PLC-ADR trading halted, news pending
Benzinga·04/02 17:15
Why Is Biodexa Pharmaceuticals (BDRX) Stock Skyrocketing Today?
TipRanks·04/02 13:12
Biodexa Pharmaceuticals announces MTX240 manufacturing pact with Syngene
TipRanks·03/31 12:47
Biodexa, Tanner Pharma launch global early access program for FAP patients
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.